Genomic Valley Biotech Limited announced earnings results for the third quarter ended December 31, 2020. For the third quarter, the company announced total revenue was INR 916,620 compared to INR 1.891 million a year ago. Net loss was INR 136,263 compared to net income of INR 927,269 a year ago. Basic loss per share was INR 0.04 compared to basic earnings per share of INR 0.3 a year ago. For the nine months, total revenue was INR 1.863 million compared to INR 5.710 million a year ago. Net loss was INR 1.754 million compared to net income of INR 1.260 million a year ago. Basic loss per share was INR 0.57 compared to basic earnings per share of INR 0.41 a year ago.